Back to results
US 10,328,025 B2Granted
Ophthalmic emulsion
AssigneeAlcon Research, Ltd.
InventorsHoward Allen Ketelson, David L. Meadows
Life of this patent
Estimating the term…
Abstract
The present invention is directed to an ophthalmic emulsion. The emulsion has a unique combination of ingredients that promotes the stability of small oil droplets within the emulsion. The emulsion also includes a mucoadhesive polymer that aid in delivering a lipid to the ocular surface.
Claims10
An ophthalmic emulsion, the emulsion comprising:
- water forming an aqueous phase;
- oil forming an oil phase;
- a hydrophilic surfactant, wherein the hydrophilic surfactant is polyoxyethylene-40-stearate;
- a hydrophobic surfactant, wherein the hydrophobic surfactant is a sorbitan tristearate;
- a charged phospholipid;
- wherein the charged phospholipid is an anionic phospholipid named dimyristoyl phosphatidylglycerol and wherein the phospholipid is present in the emulsion in a concentration from 0.05 to 7.0 percent by weight
- borate;
- a mucoadhesive galactomannan polymer;
- and
- a preservative, wherein the emulsion is free of a benzalkonium chloride,
- wherein:
- i. the oil phase is in droplets within the aqueous phase and the droplets have an average diameter that is no greater than about 1000 nm, but is at least 10 nm, wherein the average diameter is corresponding to 90% of the cumulative undersize distribution by volume measured using a Microtrac S3500 Particle Size Analyzer (Software Version 10.3.1);
- and
- ii. the borate and galactomannan polymer cooperatively act to form a gel upon instillation of the emulsion in an eye of an individual.
11 more elements
Dependencies are inferred from the claim text.